Perkins Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-481,483
| Closed | -$1.97M | – | 114 |
|
|
2022
Q1 | $1.97M | Buy |
481,483
+4,500
| +0.9% | +$18.4K | 1.62% | 22 |
|
|
2021
Q4 | $1.7M | Sell |
476,983
-63,800
| -12% | -$228K | 1.15% | 30 |
|
|
2021
Q3 | $1.97M | Sell |
540,783
-1,000
| -0.2% | -$3.64K | 1.22% | 28 |
|
|
2021
Q2 | $2.36M | Sell |
541,783
-500
| -0.1% | -$2.18K | 1.34% | 28 |
|
|
2021
Q1 | $2.23M | Buy |
542,283
+61,500
| +13% | +$253K | 1.29% | 27 |
|
|
2020
Q4 | $1.92M | Buy |
480,783
+254,250
| +112% | +$1.01M | 1.25% | 28 |
|
|
2020
Q3 | $612K | Buy |
+226,533
| New | +$612K | 0.56% | 52 |
|
|
2020
Q1 | $548K | Sell |
232,166
-24,667
| -10% | -$58.2K | 0.66% | 50 |
|
|
2019
Q4 | $1.21M | Sell |
256,833
-45,800
| -15% | -$215K | 1.08% | 31 |
|
|
2019
Q3 | $1.01M | Sell |
302,633
-72,367
| -19% | -$242K | 0.87% | 45 |
|
|
2019
Q2 | $1.23M | Sell |
375,000
-66,000
| -15% | -$217K | 0.86% | 35 |
|
|
2019
Q1 | $1.34M | Buy |
441,000
+32,000
| +8% | +$96.9K | 0.88% | 34 |
|
|
2018
Q4 | $1.11M | Sell |
409,000
-26,000
| -6% | -$70.7K | 0.86% | 33 |
|
|
2018
Q3 | $1.46M | Buy |
435,000
+117,500
| +37% | +$395K | 0.88% | 35 |
|
|
2018
Q2 | $819K | Buy |
317,500
+14,500
| +5% | +$37.4K | 0.59% | 59 |
|
|
2018
Q1 | $667K | Buy |
303,000
+51,000
| +20% | +$112K | 0.6% | 55 |
|
|
2017
Q4 | $501K | Sell |
252,000
-114,000
| -31% | -$227K | 0.48% | 64 |
|
|
2017
Q3 | $1.19M | Buy |
366,000
+356,000
| +3,560% | +$1.15M | 1.24% | 23 |
|
|
2017
Q2 | $32K | Sell |
10,000
-592,000
| -98% | -$1.89M | 0.04% | 103 |
|
|
2017
Q1 | $1.71M | Sell |
602,000
-5,000
| -0.8% | -$14.2K | 1.76% | 12 |
|
|
2016
Q4 | $1.41M | Hold |
607,000
| – | – | 1.55% | 16 |
|
|
2016
Q3 | $1.02M | Buy |
+607,000
| New | +$1.02M | 1.02% | 36 |
|